Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (151-160 of 211) with videos related to

Pageof 22
Sort By:
American Journal of Respiratory and Critical Care Medicine|March 10, 2021
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer CellsYong Huang, Justin M Oldham, Shwu-Fan Ma, et al.
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung DiseaseShehabaldin Alqalyoobi, Jennifer A Smith, Manoj V Maddali, et al.
Annals of the American Thoracic Society|August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and MethodsBonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
JAMA|May 11, 2021
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical TrialFernando J Martinez, Eric Yow, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|June 24, 2024
Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational CohortsManoj V Maddali, Andrew R Moore, Pratik Sinha, et al.
Scientific Reports|October 17, 2019
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation GenesNancy Casanova, Tong Zhou, Manuel L Gonzalez-Garay, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2023
Proteomic Biomarkers of Survival in Idiopathic Pulmonary FibrosisJustin M Oldham, Yong Huang, Swaraj Bose, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2014
The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosisLong Shuang Huang, Biji Mathew, Haiquan Li, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2017
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary FibrosisYong Huang, Shwu-Fan Ma, Milena S Espindola, et al.
Pageof 22

Showing results (151-160 of 211) with videos related to

Sort By:
Pageof 22
American Journal of Respiratory and Critical Care Medicine|March 10, 2021
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer CellsYong Huang, Justin M Oldham, Shwu-Fan Ma, et al.
American Journal of Respiratory and Critical Care Medicine|April 10, 2025
Proteomic Biomarkers of Survival in Non-IPF Interstitial Lung DiseaseShehabaldin Alqalyoobi, Jennifer A Smith, Manoj V Maddali, et al.
Annals of the American Thoracic Society|August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and MethodsBonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
JAMA|May 11, 2021
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical TrialFernando J Martinez, Eric Yow, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|June 24, 2024
Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational CohortsManoj V Maddali, Andrew R Moore, Pratik Sinha, et al.
Scientific Reports|October 17, 2019
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation GenesNancy Casanova, Tong Zhou, Manuel L Gonzalez-Garay, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
American Journal of Respiratory and Critical Care Medicine|October 17, 2023
Proteomic Biomarkers of Survival in Idiopathic Pulmonary FibrosisJustin M Oldham, Yong Huang, Swaraj Bose, et al.
American Journal of Respiratory and Critical Care Medicine|May 1, 2014
The mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosisLong Shuang Huang, Biji Mathew, Haiquan Li, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2017
Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary FibrosisYong Huang, Shwu-Fan Ma, Milena S Espindola, et al.
Pageof 22